A fourth SARS-CoV-2 mRNA vaccine in strictly seronegative kidney transplant recipients
暂无分享,去创建一个
M. Giral | J. Dantal | D. Cantarovich | G. Blancho | S. Caillard | I. Benotmane | Aurélie Meurette | C. Garandeau | C. Masset | Gabriella Gauthier-Vargas
[1] O. Thaunat,et al. Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series , 2022, Annals of Internal Medicine.
[2] O. Thaunat,et al. COVID-19 vaccination in kidney transplant recipients , 2021, Nature Reviews Nephrology.
[3] G. Tomlinson,et al. Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients , 2021, The New England journal of medicine.
[4] John D. Davis,et al. Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 , 2021, The New England journal of medicine.
[5] P. Shah,et al. Risk of Breakthrough SARS-CoV-2 Infections in Adult Transplant Recipients , 2021, Transplantation.
[6] J. Vekemans,et al. Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection , 2021, Nature Medicine.
[7] B. Preston,et al. Case Series , 2010, Toxicologic pathology.